Strikingly, FACTin treatment counteracted the effects observed in IPF hLF, supporting the involvement of the HMGA2-FACT-ATM-pH2A.X axis in this interstitial lung disease. Here, SUPT16H is linked to idiopathic pulmonary fibrosis.